Kissei Pharmaceutical
Employees
Market cap
€1.1b
Enterprise valuation
€763m (Public information from Sep 2024)
Share price
JPY3510 4547.T
Japan (HQ)
Financials
Estimates*
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 69.0b | 65.4b | 67.5b | 75.6b | 83.5b | 84.7b | 88.6b |
| % growth | 9 % | (5 %) | 3 % | 12 % | 10 % | 2 % | 5 % |
| EBITDA | 5.9b | 4.1b | 4.6b | 9.5b | 14.4b | 14.5b | 14.8b |
| % EBITDA margin | 9 % | 6 % | 7 % | 13 % | 17 % | 17 % | 17 % |
| Profit | 5.3b | 12.9b | 10.5b | 11.2b | 12.1b | 9.1b | 8.1b |
| % profit margin | 8 % | 20 % | 16 % | 15 % | 14 % | 11 % | 9 % |
| EV / revenue | 1.0x | 1.0x | 1.1x | 1.5x | 1.8x | 1.8x | 1.7x |
| EV / EBITDA | 11.8x | 16.0x | 15.9x | 11.7x | 10.7x | 10.6x | 10.4x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Kissei Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Kissei Pharmaceutical
Edit
exited